E Fougera & Co, the generic drug division of ALTANA Inc, has named Cure Autism Now (CAN) as the 2006 recipient of an annual major grant given through its philanthropic program, Fougera Cares. The $10,000 award was presented at the National Association of Chain Drug Stores Pharmacy and Technology Conference in San Diego, Calif, in August. Paul McGarty, chief executive officer (CEO) of Fougera, and David Klaum, senior vice president of commercial business operations for the company, presented the award to Peter Bell, president and CEO of CAN, at Fougera's exhibit booth at the conference.
Fougera first became aware of CAN through Rick Kerns, a prop master for the television show "ER." Kerns was working with Fougera on product placement and talked about his family's personal experiences with autism. McGarty said, "Fougera Cares provides much-needed resources to support a variety of charitable enterprises. CAN is doing landmark work to address one of the fastest-growing health epidemics in our country, and we are honored to be able to contribute to their mission."
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs